The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seki, E.
Right arrow Articles by Nakanishi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seki, E.
Right arrow Articles by Nakanishi, K.
The Journal of Immunology, 2002, 169: 3863-3868.
Copyright © 2002 by The American Association of Immunologists

Critical Roles of Myeloid Differentiation Factor 88-Dependent Proinflammatory Cytokine Release in Early Phase Clearance of Listeria monocytogenes in Mice1

Ekihiro Seki*, Hiroko Tsutsui{dagger}, Noriko M. Tsuji{ddagger}, Nobuki Hayashi{dagger}, Keishi Adachi{dagger}, Hiroki Nakano{dagger}, Shizue Futatsugi-Yumikura{dagger}, Osamu Takeuchi§, Katsuaki Hoshino§, Shizuo Akira§, Jiro Fujimoto* and Kenji Nakanishi2,{dagger}

* First Department of Surgery and {dagger} Department of Immunology and Medical Zoology, Hyogo College of Medicine, Nishinomiya, Japan; {ddagger} Laboratory of Molecular Immunology, Department of Molecular Biology and Immunology, National Institute for Agrobiological Sciences, Tsukuba, Japan; § Department of Host Defenses, Research Institute for Microbial Diseases, Osaka University, Suita, Japan; and Core Research for Evolutional Science and Technology, Japan Science and Technology Corp., Tokyo, Japan


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Listeria monocytogenes (LM), a facultative intracellular Gram-positive bacterium, often causes lethal infection of the host. In this study we investigated the molecular mechanism underlying LM eradication in the early phase of infection. Upon infection with LM, both IL-12 and IL-18 were produced, and then they synergistically induced IFN-{gamma} production, leading to normal LM clearance in the host. IFN-{gamma} knockout (KO) mice were highly susceptible to LM infection. IL-12/IL-18 double knockout mice were also highly susceptible. Their susceptibility was less than that of IFN-{gamma} KO mice, but more than that of single IL-12 or IL-18 KO mice. Mice deficient in myeloid differentiation factor 88 (MyD88), an essential adaptor molecule used by signal transduction pathways of all members of the Toll-like receptor (TLR) family, showed an inability to produce IL-12 and IFN-{gamma} following LM infection and were most susceptible to LM. Furthermore, MyD88-deficient, but not IFN-{gamma}-deficient, Kupffer cells could not produce TNF-{alpha} in response to LM in vitro, indicating the importance of MyD88-dependent TNF-{alpha} production for host defense. As TLR2 KO, but not TLR4 KO, mice showed partial impairment in their capacity to produce IL-12, IFN-{gamma}, and TNF-{alpha}, TLR2 activation partly contributed to the induction of IL-12-mediated IFN-{gamma} production. These results indicated a critical role for TLRs/MyD88-dependent IL-12/TNF-{alpha} production and for IL-12- and IL-18-mediated IFN-{gamma} production in early phase clearance of LM.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Listeria monocytogenes (LM)3 is a Gram-positive facultative intracellular bacterium that often causes life-threatening infections in an immunocompromised host, including newborns and elderly people (1, 2, 3). In host liver, LM invades and replicates in hepatocytes and Kupffer cells, tissue macrophages (2). The activation of the host’s innate immune system is critical for LM eradication in the early phase of infection (2, 3, 4). LM-infected macrophages produce IL-12 and IL-18 that synergistically induce NK cells and dendritic cells to produce IFN-{gamma} (4, 5, 6, 7, 8, 9, 10), which subsequently activates macrophages and neutrophils to kill LM via production of listericidal molecules, such as NO (2, 11). Therefore, IL-12 and IL-18 seem to play an essential role in early phase clearance of LM by induction of IFN-{gamma}.

Toll-like receptors (TLRs) have been identified as signaling receptors of the innate immune system and recognize corresponding pathogen-associated molecular patterns (12). TLR2 recognizes Gram-positive bacterial components, including peptide glycan and lipoproteins (12, 13). Studies using TLR2-transfected Chinese hamster ovary cells revealed TLR2 as a signaling receptor for LM products (14). TLR4 is reported to act as a signaling receptor of LPS, Gram-negative bacterial component (13, 15, 16, 17).

Myeloid differentiation factor 88 (MyD88) is an adaptor molecule essential for signaling through TLR (12, 18, 19). Pathogen-associated molecular patterns induce recruitment of MyD88 to the cytoplasmic domain of TLR, resulting in a relay of signal and activation of NF-{kappa}B that causes transcription of IL-12, TNF-{alpha}, and other inflammatory cytokines. Furthermore, MyD88 plays a critical role in IL-18R-mediated IL-18 signaling that induces IFN-{gamma} production from IL-12-stimulated innate or acquired immune cells (20). These results suggest the importance of MyD88 in host defense against various pathogens. Indeed, MyD88 knockout (KO) mice are highly susceptible to Staphylococcus aureus infection and show the disability to produce proinflammatory cytokines (13). However, our recent study demonstrated the presence of MyD88-independent IL-18 release in LM-infected mice (9). Therefore, it is important to understand the protective role of TLR/MyD88 in LM infection.

In this study we have investigated molecular mechanisms of clearance of LM in mice. IL-12- or IL-18-deficient (KO) mice lacked the capacity to produce detectable levels of IFN-{gamma} in their sera. These mice showed marked and moderate susceptibility to LM, respectively. IFN-{gamma} KO mice entirely lacking the ability to produce IFN-{gamma}; IL-12/IL-18 double KO (DKO) mice, lacking upstream cytokines for IFN-{gamma} induction, showed much higher susceptibility to LM. However, we found that MyD88 KO mice that cannot produce IFN-{gamma}, IL-12, and TNF-{alpha} are the most susceptible to LM. These results suggested that both IFN-{gamma} and TNF-{alpha} are essential for host defense against LM.

We conclude that MyD88 is a critical adaptor molecule essentially required for full activation of innate immune system.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice

Specific pathogen-free female C57BL/6 mice (6–8 wk old) were purchased from Clea Japan (Osaka, Japan). IL-12 KO mice were provided by Dr. J. Magram (Roche Institute of Molecular Biology, Nutley, NJ) (21) and were backcrossed with C57BL/6 mice, and female F8 mice (6–9 wk old) were used for this study. IL-18 KO mice (22) and IFN-{gamma} KO mice (23) were backcrossed with C57BL/6 mice, and female F8 mice (6–9 wk old) were used. To obtain C57BL/6-background IL-12/IL-18 DKO mice (6–8 wk old), F8 mice from C57BL/6-backcrossed IL-18 KO mice were crossed with F8 mice of C57BL/6-backcrossed IL-12 KO mice. IL-18R{alpha} KO mice (24) were backcrossed with C57BL/6 mice, and female F10 mice (6–9 wk old) were used. TLR2 KO mice (13), TLR4 KO mice (15), and MyD88 KO mice (20) were backcrossed with C57BL/6 mice, and F2 female mice (6–9 wk old) were used. To obtain TLR2/TLR4 DKO mice (6–9 wk old), F2 mice from C57BL/6-backcrossed TLR2 KO mice were crossed with F2 mice from C57BL/6-backcrossed TLR4 KO mice.

Assay for cytokines

Concentrations of IFN-{gamma}, IL-12p40, and TNF-{alpha} were determined by ELISA kits (Genzyme, Boston, MA).

Infection with LM

LM 43251 (American Type Culture Collection, Manassas, VA) was cultured in Trypsicase Soy Broth (BD Biosciences, Cockeysville, MD). Mice with various genotypes were i.v. inoculated with 5 x 105 LM. At the indicated time points serum was sampled for measurements of various cytokines. On day 3 livers from mice with various genotypes were homogenized, and the LM titer in each homogenate was determined according to the method described previously (4). The survival of various genotype mice inoculated with 5 x 105, 5 x 104, or 5 x 103 LM was judged every 12 h until day 14 after infection.

Kupffer cell preparation

Kupffer cells were prepared as previously shown (9). Culture medium was RPMI 1640 supplemented with 10% FCS, 50 µM 2-ME, and 2 mM L-glutamine. The cells (1 x 106/ml) were cultured with live LM (1 x 106 or 1 x 107/ml). After 1 h in culture, penicillin and streptomycin were added to the culture medium at final concentrations of 100 U/ml and 100 µg/ml, respectively, to limit the growth of LM, the cells were incubated for an additional 24 h (5), and cytokine levels in each supernatant were determined by ELISA.

Histology

Mice were inoculated with 5 x 105 LM and were killed 72 h after infection. Their liver specimens were sampled and fixed in 10% buffered formalin, and the slides were stained with H&E.

Statistics

All data are shown as the mean ± SD of triplicate determinations. Significance between control and experimental groups was examined with unpaired Student’s t test. A value of p < 0.05 was regarded as significant.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Both IL-12 and IL-18 are required for induction of IFN-{gamma} production at the early infectious phase of LM

It is well known that IFN-{gamma} is critical for early phase clearance of LM (1, 2, 3, 4, 25). We wanted to clarify whether IL-12 and/or IL-18 play an essential role in early induction of IFN-{gamma} production following LM infection. We measured IFN-{gamma} levels in the sera of mice with various genotypes after LM infection (Fig. 1Go). In wild-type (WT) mice the serum IFN-{gamma} level increased and peaked at 24 h postinfection, while IFN-{gamma} was undetectable in the sera of IL-12/IL-18 DKO mice. IL-12 or IL-18 single-KO mice also showed undetectable levels of IFN-{gamma} in their sera. These results strongly indicated the requirement for both IL-12 and IL-18 for IFN-{gamma} production in LM-infected mice. LM-infected MyD88 KO mice also displayed an undetectable level of IFN-{gamma} in their sera, further substantiating our previous reports that MyD88 is required for IL-18-mediated IFN-{gamma} induction (9, 20).



View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 1. Requirement of both IL-12 and IL-18 for IFN-{gamma} induction in early LM infection. WT, IL-18 KO, IL-12 KO, IL-12/IL-18 DKO (DKO), and MyD88 KO mice were i.v. inoculated with 5 x 105 LM. Sera at 0, 6, 12, 24, 48, and 72 h postinfection were sampled for the measurement of IFN-{gamma} levels by ELISA. Data are the mean ± SD of five mice in each experimental group. Similar results were obtained in three independent experiments.

 
Critical role of MyD88 in eradication of LM in the liver

As both IL-12 and IL-18 contribute to IFN-{gamma} accumulation (Fig. 1Go), we investigated whether both IL-12 and IL-18 are also responsible for early phase LM clearance in the liver. IL-18 KO mice and IL-12 KO mice showed partial and severe impairment in LM eradication, respectively, compared with WT mice (Fig. 2GoA). As expected, IL-12/IL-18 DKO and IFN-{gamma} KO mice showed striking impairment in LM eradication. IFN-{gamma} KO mice had the largest CFU counts in their livers (Fig. 2GoA), indicating that IFN-{gamma} plays an essential role in LM eradication from the liver.



View larger version (39K):
[in this window]
[in a new window]
 
FIGURE 2. MyD88 is indispensable for LM clearance via induction of both IFN-{gamma} and TNF-{alpha}. A, On day 3 after inoculation, liver was sampled from WT, IL-12 KO, IL-18 KO, IL-12/IL-18 DKO (DKO), and IFN-{gamma} KO (GKO) mice. Bacterial burden in the liver was calculated. Data are the mean ± SD of five mice in each experimental group. Similar results were obtained in three independent experiments. *, p < 0.05; **, p < 0.01. B, On day 3 after inoculation, liver was sampled from WT, IL-18R{alpha} KO (IL-18RKO), IFN-{gamma} KO (GKO), or MyD88 KO mice. Bacterial burden in the livers was calculated. Data are the mean ± SD of five mice in each experimental group. Similar results were obtained in three independent experiments. *, p < 0.05; **, p < 0.01. C, Sera were obtained from WT, IL-18 KO, IL-12 KO, IFN-{gamma} (GKO), or MyD88 KO mice at 24 h postinfection for measurement of IL-12p40 levels by ELISA. Data are the mean ± SD of five mice in each experimental group. Similar results were obtained in three independent experiments. D, Kupffer cells from WT, IL-18 KO, IL-12 KO, IL-12/IL-18 DKO (DKO), IFN-{gamma} KO (GKO), or MyD88 KO mice were incubated with live LM (1 x 106/ml) for 24 h, and TNF-{alpha} levels in each supernatant were determined by ELISA. Data are presented as the mean ± SD of triplicate cultures. Similar results were obtained in three independent experiments. ND, not detectable.

 
IL-18 seemed to weakly contribute to early LM eradication in the liver (Fig. 2GoA). Furthermore, the absence of expression of IL-18 or IL-18R{alpha} did not affect IL-12 production in LM-infected mice (Fig. 2GoC and data not shown). In contrast, MyD88 KO mice did not produce IL-12 (Fig. 2GoC), although they could produce IL-18 (9), suggesting a contribution of MyD88 to IL-12 production.

Because MyD88 is an essential adaptor molecule for IL-18R-mediated signaling (20), we compared CFU counts in the livers of IL-18R{alpha} KO mice with those in MyD88 KO mice. Like IL-18 KO mice (Fig. 2GoA), IL-18R{alpha} KO mice showed much better LM clearance than MyD88 KO mice, indicating only moderate contribution of IL-18 signaling to LM clearance (Fig. 2GoB).

MyD88-dependent TNF-{alpha} production is required for LM eradication

We next investigated whether defects in LM clearance in MyD88 KO mice are solely due to their disability to produce IFN-{gamma}. For this purpose we compared listerial burden in the liver between IFN-{gamma} KO and MyD88 KO mice. As shown in Fig. 2GoB, bacterial burden in the liver of MyD88 KO mice was significantly heavier than that in IFN-{gamma} KO mice (p < 0.05).

Listerial burden in the liver of MyD88 KO mice was larger than that in IFN-{gamma} KO mice (Fig. 2GoB), indicating the importance of an additional factor(s) that was produced in a MyD88-dependent manner. As TNF-{alpha} is well known as another important factor for LM clearance (26, 27, 28), we simultaneously investigated the capacity of MyD88 KO mice to produce TNF-{alpha} upon LM infection. TNF-{alpha} was undetectable in the sera of LM-infected WT mice. Therefore, we examined the capacity of macrophages to produce TNF-{alpha} in response to LM in vitro. As shown in Fig. 2GoD, WT Kupffer cells produced TNF-{alpha} when stimulated with LM. IL-12- or IL-18-dificient or IL-12/IL-18 doubly deficient Kupffer cells produced TNF-{alpha} comparably to WT Kupffer cells (Fig. 2GoD), indicating that IL-12 and IL-18 are dispensable for TNF-{alpha} production. IFN-{gamma}-deficient cells secreted slightly less TNF-{alpha} (Fig. 2GoD), indicating a minor role of IFN-{gamma} in TNF-{alpha} production. In contrast, MyD88-deficient Kupffer cells did not produce TNF-{alpha}, suggesting the involvement of TNF-{alpha} in LM clearance.

TLR/MyD88 is required for IL-12 release upon LM infection

MyD88 is essential for IL-12 and TNF-{alpha} production upon LM infection (Fig. 2Go, C and D) (9). Next, we investigated what types of TLRs are involved in the induction of IL-12 and TNF-{alpha}. As shown in Fig. 3GoA, TLR2 KO mice, but not TLR4 KO mice, showed reduced IL-12p40 production following LM infection. Similarly, TLR2/TLR4 DKO mice showed a reduction in their capacity to produce IL-12, indicating that TLR2 partly contributes to IL-12 production independently of TLR4. Consistent with our previous report (9), MyD88 KO mice failed to produce IL-12 (Fig. 3GoA), although they secreted IL-18 (data not shown). TLR2 KO mice and TLR2/TLR4 DKO mice, but not TLR4 KO mice, displayed less IFN-{gamma} in their sera than did WT mice post-LM infection (Fig. 3GoB). As expected from the results with IL-12 (Fig. 3GoA), MyD88 KO mice were incapable of producing IFN-{gamma} in their sera (Fig. 3GoB). Serum levels of IFN-{gamma} appeared to correlate well with those of IL-12 in various mutant mice, suggesting that IL-12 is principally responsible for determining the IFN-{gamma} level. These results suggested the importance of TLR2 and possibly other TLRs, except for TLR4, in IL-12-dependent IFN-{gamma} production after LM challenge.



View larger version (37K):
[in this window]
[in a new window]
 
FIGURE 3. Partial involvement of TLR2 in IL-12 and IFN-{gamma} increase upon LM infection. A and B, After inoculation, sera from WT, TLR2 KO, TLR4 KO, TLR2/TLR4 DKO (TLR2/4 DKO), and MyD88 KO mice were sampled at 24 h postinfection for the measurement of IL-12 (A) and IFN-{gamma} (B) levels by ELISA. Data are the mean ± SD of five mice in each experimental group. C and D, Kupffer cells from WT, TLR2 KO, TLR4KO, or MyD88KO mice were incubated with live LM (1 x 106/ml (C) or 1 x 107/ml (D)) for 24 h, and TNF-{alpha} levels in each supernatant were determined by ELISA. Data are presented as the mean ± SD of triplicate cultures. Similar results were obtained in three independent experiments. *, p < 0.05. ND, not detectable.

 
We investigated whether TLR2 is also important for TNF-{alpha} production in response to LM. After being stimulated with a small number of the bacteria, TLR2-deficient Kupffer cells, unlike TLR4-deficient cells, produced much less TNF-{alpha}, as in MyD88-deficient cells (Fig. 3GoC). However, upon challenge with a large number of LM, TLR2-deficient cells produced more TNF-{alpha} than MyD88-deficient Kupffer cells (Fig. 3GoD). Collectively, LM infection induces both IFN-{gamma} and TNF-{alpha} production, dependent in part on TLR2 and perhaps other TLRs.

MyD88 is critical for neutrophil recruitment into the liver

As both IFN-{gamma} and TNF-{alpha} are involved in the recruitment of neutrophils, potent effector cells (29, 30, 31, 32), we investigated inflammatory responses in the liver of the various mutant mice postinfection. LM-infected WT mice had large inflammatory foci consisting of numerous neutrophils in the liver (Fig. 4Go, A and B). In livers of IL-18 KO or IL-12KO mice we could not find significant differences in the levels of inflammatory responses compared with WT mice (data not shown). The inflammatory foci in livers of IFN-{gamma} KO mice contained fewer neutrophils in their population (Fig. 4Go, C and D), indicating the importance of IFN-{gamma} in the recruitment of neutrophils. Somewhat surprisingly, IL-12/IL-18 DKO mice showed a dense infiltration of neutrophils (data not shown), while IFN-{gamma} KO mice did not, suggesting the failure of IL-12 and IL-18 to completely cover the function of IFN-{gamma}. MyD88 KO mice had much smaller foci, composed of few neutrophils, than the other mutant mice, even including IFN-{gamma} KO mice (Fig. 4Go, C–F), suggesting that MyD88 participates in neutrophil recruitment via induction of both IFN-{gamma} and TNF-{alpha}. There were no remarkable differences in the pathological changes in livers between WT and TLR4 KO mice, but the foci in TLR2 KO mice contained fewer neutrophils than those in WT or TLR4 KO mice (Fig. 4Go, G–J). This may be explained by the partial impairment in the production of both IFN-{gamma} and TNF-{alpha} in TLR2 KO mice (Fig. 3Go, B and C). Collectively, these results suggest the essential role of both IFN-{gamma} and TNF-{alpha} in the early phase clearance of LM via activation and recruitment of effector cells in the liver.



View larger version (69K):
[in this window]
[in a new window]
 
FIGURE 4. Requirement of MyD88 for hepatic recruitment of neutrophils. On day 3 after inoculation (5 x 105 CFU of LM), liver specimens of WT (A and B), IFN-{gamma} KO (GKO; C and D) MyD88 KO (E and F), TLR2 KO (G and H), or TLR4 KO (I and J) mice were sampled for histological study. Representative data from three mice in each experimental group of three independent experiments with similar results are shown. H&E staining was used. Original magnification: A, C, E, G, and I, x100; B, D, F, H, and J, x200. Closed arrow head, neutrophils; asterisk, macrophages.

 
MyD88 is essential for resistance to LM

Finally, we investigated the mortality of mice with various genotypes after inoculation with LM. As shown in Fig. 5Go, WT mice inoculated with the highest number of LM survived up to 14 days postinfection, at which time they were sacrificed. The survival rate of IL-18 KO mice was less than that of WT mice only when they were infected with the highest number of LM (5 x 105 bacteria; Fig. 5GoA). All IL-12 KO and IL-12/IL-18 DKO mice died by day 5 postinfection with the largest number of LM (Fig. 5GoA). However, inoculation with a lesser number of LM (5 x 104 bacteria) revealed that IL-12/IL-18 DKO mice were more susceptible than IL-12 KO mice (Fig. 5GoB). Moreover, all the IL-12/IL-18 DKO mice survived, but 80% of IFN-{gamma} KO mice succumbed upon infection with the smallest number of LM (5 x 103 bacteria; Fig. 5GoC). These results strongly indicated the essential involvement of IFN-{gamma} in host defense against LM infection. Consistent with their disability to produce both IFN-{gamma} and TNF-{alpha} ( Figs. 1–3GoGoGo), MyD88 KO mice were most susceptible to LM (Fig. 5Go). The mortality well paralleled the LM titer in the liver (Fig. 2Go) and the intensity of neutrophil recruitment (Fig. 4Go). Collectively, LM-induced MyD88-mediated IL-12 and TNF-{alpha} production is essential for protection of mice from fatal LM infection.



View larger version (21K):
[in this window]
[in a new window]
 
FIGURE 5. MyD88 determines host resistance to LM. The survival rates of MyD88 KO ({blacktriangleup}), IFN-{gamma} KO (GKO; {circ}), IL-12/IL-18 DKO (DKO; {diamondsuit}), IL-12 KO ({triangleup}), IL-18 KO ({diamond}), and WT (•) mice after i.v. injection of 5 x 105 (A), 5 x 104 (B), or 5 x 103 (C) CFU of LM/mouse are shown. Survival was assessed every 12 h for 14 days. Each experimental group consisted of eight (A) or five (B and C) mice. Similar results were obtained in two independent experiments.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Initial infection with microbes activates host innate immunity through TLRs to promptly expel the pathogen (12). Insufficient early eradication of the pathogen is sequentially restored by activated adaptive immunity, resulting in successful clearance of the pathogens. In contrast to the involvement of innate immunity in the initial infection, adaptive immunity promptly participates in clearance of the pathogen upon reinfection. LM is an intracellular parasitic bacterium against which Th1 cells have been reported to be essentially required (3). However, the innate immune responses developing in initial LM infection often determine the outcome of the host, especially the immunocompromised host (2). The effector mechanism in the innate immune response to LM consists of phagocytosis and NK cell activation. As previously reported, innate immunity effectively exerts its protective action against pathogen when they are efficiently activated by endogenous and/or exogenous IL-12 and IL-18, which in combination have capacity to induce IFN-{gamma} production by innate and adaptive immune cells, including T cells, B cells, NK cells, macrophages, and dendritic cells (10). Here, we illustrated the importance of endogenous IL-12 and IL-18 in early phase clearance of LM (Figs. 2Go and 5Go). Although the relative roles of IL-12 and IL-18, which are essential for IFN-{gamma} production in vivo (Fig. 1Go), are still unclear in innate immunity, our present study clearly showed that IL-12 is much more important in local LM elimination than IL-18 (Fig. 2Go). We also revealed that MyD88 is essential for induction of IL-12 plus IL-18-dependent IFN-{gamma} production (Figs. 1Go and 2Go), because it allows signaling through TLR and IL-18R, which are activated by LM and IL-18, respectively. In studies using IFN-{gamma} KO and MyD88 KO mice we showed an additional role of MyD88 as an essential molecule to induce production of TNF-{alpha} (Fig. 2GoD). MyD88-dependent IFN-{gamma} in combination with MyD88-dependent TNF-{alpha} accomplish host defense against LM with efficient recruitment of neutrophils in the liver (Figs. 4Go and 5Go). Our present results revealed the importance of innate immune responses that are definitively triggered by TLR/MyD88-dependent pathways.

Very recently, Neighbors et al. (33) reported that treatment of BALB/c mice with mAb against IL-18R{beta}, a signaling component of IL-18R, renders them highly susceptible to sublethal numbers of LM compared with neutralizing anti-IL-12p40 mAb. Our present results using IL-12 KO mice on the C57BL/6 background indicated that endogenous IL-12p40 is more dominantly involved in LM clearance than IL-18. There are several possibilities that account for this discrepancy. First, as noted above, they used LM-susceptible BALB/c mice, while we used LM-resistant C57BL/6 background mice. Second, they used anti-IL-18R{beta} mAb-treated mice, while we used IL-18 KO and IL-18R{alpha} KO mice. Both IL-18 KO and IL-18R{alpha} KO mice had the same immune responses after LM infection (Fig. 2Go, A and B), demonstrating that IL-18R{alpha} is necessary and sufficient for IL-18 signaling. Therefore, we suspect that their mAb might inhibit not only IL-18 signaling but also signaling of an unknown factor(s) that uses IL-18R {beta}-chain. Third, the discrepancy might be due to the difference in the target tissues examined. The liver, which we manipulated, is composed of unique residential lymphocytes, including NK cells and NKT cells, which are meager in the spleen they used.

As previously reported, IL-18 has capacity to induce TNF-{alpha} production by macrophage upon LM infection (33). However, IL-18 deficiency does not reduce TNF-{alpha} production in response to LM (Fig. 2GoD), indicating that endogenous IL-18 does not participate in TNF-{alpha} production, at least in macrophage levels. Furthermore, we showed that the absence of IL-18 does not influence IL-12p40 production (Fig. 2GoC). Thus, apparently IL-18 does not play a major role in the production of TNF-{alpha} or IL-12 after LM infection.

IL-12 KO mice were more susceptible than IL-18 KO mice (Fig. 5Go), although both failed to show a detectable serum level of IFN-{gamma} (Fig. 1Go). At present we have no definitive explanation for this difference. However, IL-12 KO mice may have no capacity to develop Th1 cells, while IL-18 KO mice have such potentiality to develop Th1 cells following infection in the target organs (10, 22). We measured serum levels of IFN-{gamma}. Measurement of local levels of IFN-{gamma} and determination of cells that produce IFN-{gamma} in the liver might be important for understanding the difference in the host resistance to LM infection of IL-18 KO and IL-12 KO mice.

Livers of IFN-{gamma} KO mice contain more LM titer than those of IL-12/IL-18 DKO mice (Fig. 2Go). Other factors, in addition to IL-12 and IL-18, might contribute to IFN-{gamma}-dependent LM clearance. IL-15 is a candidate because IL-15 synergizes with IL-18 and/or IL-12 for induction of IFN-{gamma} (Ref. 34 and our unpublished observations) and is synthesized by macrophages upon stimulation with microbe and microbe products, including LM (34, 35).

Furthermore, we tested the involvement of TLR members in LM infection to induce proinflammatory cytokine production. Because most bacterial cell wall components, either from Gram-positive or -negative bacteria, are recognized by TLR2 or TLR4, respectively, we used TLR2 KO mice and TLR4 KO mice as host (13). We found that TLR2 KO mice showed a relatively poor response to LM infection in terms of IL-12, IFN-{gamma}, and TNF-{alpha} production (Fig. 3Go). Therefore, TLR2 seems to be partly involved in LM signaling. In contrast, MyD88 KO mice completely lacked the capacity to produce IL-12 and TNF-{alpha} upon LM infection and to respond to IL-12 plus IL-18 by IFN-{gamma} production (Fig. 3Go). Thus, TLR2 might form heterodimer by association with another TLR member(s) to exert its role as a signaling molecule. Further study is required for identification of other TLRs involved in the response to LM.

Recruitment of neutrophils in the liver requires both TNF-{alpha} and IFN-{gamma}. WT mice had large inflammatory foci composed of many neutrophils in their livers, while IFN-{gamma} KO and MyD88 KO mice showed intermediate-sized foci with a small number of neutrophils and small foci containing few neutrophils, respectively (Fig. 4Go). These results substantiate further that MyD88-dependent IFN-{gamma} and TNF-{alpha} production plays an essential role in LM clearance in the early infectious phase via activation and recruitment of effector cells.

In summary, our study showed that both IL-12 and IL-18 contribute to IFN-{gamma} production in LM infection. In addition, IL-12 is more profoundly involved than IL-18 in LM eradication in the liver. Furthermore, MyD88 plays a pivotal role in early phase clearance of LM through induction of IFN-{gamma} and TNF-{alpha} via TLR signaling. Taken together, these findings show that MyD88 is essential for determining host resistance to various microorganisms, including LM, during innate phase immune response.


    Acknowledgments
 
We thank Y. Inamoto, Y. Tsumura, N. Nakano, and M. Uemura for excellent secretarial assistance and T. Mizobuchi and K. Mitani for excellent technical assistance.


    Footnotes
 
1 This work was supported in part by a Hyogo College of Medicine Research Grant and a Hitec Research Center Grant from the Ministry of Education, Science and Culture, Japan. Back

2 Address correspondence and reprint requests to Dr. Kenji Nakanishi, Department of Immunology and Medical Zoology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Japan. E-mail address: nakaken{at}hyo-med.ac.jp Back

3 Abbreviations used in this paper: LM, Listeria monocytogenes; KO, knockout; DKO, double KO; MyD88, myeloid differentiation factor 88; TLR, Toll-like receptor; WT, wild type. Back

Received for publication April 9, 2002. Accepted for publication July 24, 2002.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Mocci, S., S. A. Dalrymple, R. Nishinakamura, R. Murray. 1997. The cytokine stew and innate resistance to L. monocytogenes. Immunol. Rev. 158:107.[Medline]
  2. Cousens, L. P., E. J. Wing. 2000. Innate defenses in the liver during Listeria infection. Immunol. Rev. 174:150.[Medline]
  3. Edelson, B. T., E. R. Unanue. 2000. Immunity to Listeria infection. Curr. Opin. Immunol. 12:425.[Medline]
  4. Andersson, A., W. J. Dai, J. P. Di Santo, F. Brombacher. 1998. Early IFN-{gamma} production and innate immunity during Listeria monocytogenes infection in the absence of NK cells. J. Immunol. 161:5600.[Abstract/Free Full Text]
  5. Ohteki, T., T. Fukao, K. Suzue, C. Maki, M. Ito, M. Nakamura, S. Koyasu. 1999. IL-12-dependent IFN {gamma} production by CD8{alpha}+ lymphoid dendritic cells. J. Exp. Med. 12:1981.
  6. Fukao, T., S. Matsuda, S. Koyasu. 2000. Synergistic effects of IL-4 and IL-18 on IL-12-dependent IFN-{gamma} production by dendritic cells. J. Immunol. 164:64.[Abstract/Free Full Text]
  7. Tripp, C. S., S. F. Wolf, E.R. Unanue. 1993. IL-12 and tumor necrosis factor {alpha} are costimulators of IFN {gamma} production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and IL-10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90:3725.[Abstract/Free Full Text]
  8. Tripp, C. S., M. K. Gately, J. Hakimi, P. Lung, E. R. Unanue. 1994. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice: reversal by IFN-{gamma}. J. Immunol. 152:1883.[Abstract]
  9. Seki, E., H. Tsutsui, H. Nakano, N. M. Tsuji, K. Hoshino, O. Adachi, K. Adachi, S. Futatsugi, K. Kuida, O. Takeuchi, et al 2001. LPS-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1{beta}. J. Immunol. 166:2651.[Abstract/Free Full Text]
  10. Nakanishi, K., T. Yoshimoto, H. Tsutsui, H. Okamura. 2001. IL-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19:423.[Medline]
  11. Beckerman, K. P., H. W. Rogers, J. A. Corbett, R. D. Schreiber, M. L. McDaniel, E. R. Unanue. 1993. Release of nitric oxide during the T cell independent pathway of macrophage activation. J. Immunol. 150:888.[Abstract]
  12. Akira, S., K. Takeda, T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675.[Medline]
  13. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11:443.[Medline]
  14. Flo, T. H., O. Halaas, E. Lien, L. Ryan, G. Teti, D. T. Golenbock, A. Sunda, T. Espevik. 2000. Human Toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or LPS. J. Immunol. 164:2064.[Abstract/Free Full Text]
  15. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, S. Akira. 1999. Toll-like receptor 4-deficient mice are hyporesponsive to LPS: evidence for TLR4 as the Lps gene product. J. Immunol. 162:3749.[Abstract/Free Full Text]
  16. Poltorak, A., X. He, I. Smirnova, M.-Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085.[Abstract/Free Full Text]
  17. Qureshi, S. T., L. Lariviere, G. Leveque, S. Clermont, K. J. Moore, P. Gros. 1999. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 18:615.
  18. O’Neill, L. A., C. A. Dinarello. 2000. The IL-1 receptor/Toll-like receptor superfamily: crucial receptors for inflammation and host defense. Immunol. Today 21:206.[Medline]
  19. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11:115.[Medline]
  20. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143.[Medline]
  21. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C. Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, M. K. Gately. 1996. IL-12-deficient mice are defective in IFN-{gamma} production and type 1 cytokine responses. Immunity 4:471.[Medline]
  22. Takeda, K., H. Tsutsui, T. Yoshimoto, O. Adachi, N. Yoshida, T. Kishimoto, H. Okamura, K. Nakanishi, S. Akira. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8:383.[Medline]
  23. Tagawa, Y., K. Sekikawa, Y. Iwakura. 1997. , Suppression of Concanavalin A-induced hepatitis in IFN-{gamma}-/- mice, but not in TNF-{alpha}-/- mice. J. Immunol. 159:1418.[Abstract]
  24. Hoshino, K., H. Tsutsui, T. Kawai, K. Takeda, K. Nakanishi, S. Akira. 1999. Generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J. Immunol. 162:5041.[Abstract/Free Full Text]
  25. Gregory, S. H., E. J. Wing. 1993. IFN-{gamma} inhibits the replication of Listeria monocytogenes in hepatocytes. J. Immunol. 151:1401.[Abstract]
  26. Bancroft, G. J., K. C. Sheehan, R. D. Schreiber, E. R. Unanue. 1989. Tumor necrosis factor is involved in the T cell independent pathway of macrophage activation in SCID mice. J. Immunol. 143:127.[Abstract]
  27. Wherry, J. C., R. D. Screiber, E. R. Unanue. 1991. Regulation of {gamma} IFN production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli. Infect. Immun. 59:1709.[Abstract/Free Full Text]
  28. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Konygen, A. Althage, R. Zinkernagel, M. Steinmetz, H. Bluethmann. 1993. Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798.[Medline]
  29. Rogers, H. W., E. R. Unanue. 1993. Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect. Immun. 61:5090.[Abstract/Free Full Text]
  30. Conlan, J. W., R. J. North. 1991. Neutrophil-mediated dissolution of infected host cells as a defense strategy against a facultative intracellular bacterium. J. Exp. Med. 174:741.[Abstract/Free Full Text]
  31. Langermans, J. A. M., D. M. Mayanski, P. H. Nibbering, M. E. B. Van der Hulst, J. S. Van de Gevel, R. Van Furth. 1994. Effect of IFN-{gamma} and endogenous TNF on the histopathological changes in the liver of Listeria monocytogenes-infected mice. Immunology 81:192.[Medline]
  32. Dai, W. J., W. Bartens, G. Koehler, M. Hufnagel, M. Kopf, F. Brombacher. 1997. Impaired macrophage listericidal and cytokine activities are responsible for the rapid death of Listeria monocytogenes-infected IFN-{gamma} receptor-deficient mice. J. Immunol. 158:5297.[Abstract]
  33. Neighbors, M., X. Xu, F. J. Barrat, S. R. Ruuls, T. Churakova, R. Debets, J. F. Bazan, R. A. Kastelein, J. S. Abrams, A. O’Garra. 2001. A critical role for IL-18 in primary and memory effector responses to Listeria monocytogenes that extends beyond its effects on interferon {gamma} production. J. Exp. Med. 194:343.[Abstract/Free Full Text]
  34. Ohteki, T., K. Suzue, C. Maki, T. Ota, S. Koyasu. 2001. Critical role of IL-15-IL-15R for Ag-presenting cell functions in the innate immune response. Nat. Immunol. 2:1138.[Medline]
  35. Liu, T., H. Nishimura, T. Matsuguchi, Y. Yoshikai. 2000. Differences in IL-12 and -15 production by dendritic cells at the early stage of Listeria monocytogenes infection between BALB/c and C57BL/6 mice. Cell. Immunol. 202:31.[Medline]



This article has been cited by other articles:


Home page
J. Immunol.Home page
T. Jia, I. Leiner, G. Dorothee, K. Brandl, and E. G. Pamer
MyD88 and Type I Interferon Receptor-Mediated Chemokine Induction and Monocyte Recruitment during Listeria monocytogenes Infection
J. Immunol., July 15, 2009; 183(2): 1271 - 1278.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Mosa, C. Trumstedt, E. Eriksson, O. Soehnlein, F. Heuts, K. Janik, A. Klos, O. Dittrich-Breiholz, M. Kracht, A. Hidmark, et al.
Nonhematopoietic Cells Control the Outcome of Infection with Listeria monocytogenes in a Nucleotide Oligomerization Domain 1-Dependent Manner
Infect. Immun., July 1, 2009; 77(7): 2908 - 2918.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A Mencin, J Kluwe, and R F Schwabe
Toll-like receptors as targets in chronic liver diseases
Gut, May 1, 2009; 58(5): 704 - 720.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. S. Haring and J. T. Harty
Interleukin-18-Related Genes Are Induced during the Contraction Phase but Do Not Play Major Roles in Regulating the Dynamics or Function of the T-Cell Response to Listeria monocytogenes Infection
Infect. Immun., May 1, 2009; 77(5): 1894 - 1903.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S.-C. Lee, S.-A Ju, B.-H. Sung, S.-K. Heo, H. R. Cho, E. A. Lee, J. D. Kim, I. H. Lee, S.-M. Park, Q. T. Nguyen, et al.
Stimulation of the Molecule 4-1BB Enhances Host Defense against Listeria monocytogenes Infection in Mice by Inducing Rapid Infiltration and Activation of Neutrophils and Monocytes
Infect. Immun., May 1, 2009; 77(5): 2168 - 2176.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Jiang, R. Sun, R. Zhou, H. Wei, and Z. Tian
TLR-9 Activation Aggravates Concanavalin A-Induced Hepatitis via Promoting Accumulation and Activation of Liver CD4+ NKT Cells
J. Immunol., March 15, 2009; 182(6): 3768 - 3774.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Lochner, K. Kastenmuller, M. Neuenhahn, H. Weighardt, D. H. Busch, W. Reindl, and I. Forster
Decreased Susceptibility of Mice to Infection with Listeria monocytogenes in the Absence of Interleukin-18
Infect. Immun., September 1, 2008; 76(9): 3881 - 3890.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Hara, K. Tsuchiya, T. Nomura, I. Kawamura, S. Shoma, and M. Mitsuyama
Dependency of Caspase-1 Activation Induced in Macrophages by Listeria monocytogenes on Cytolysin, Listeriolysin O, after Evasion from Phagosome into the Cytoplasm
J. Immunol., June 15, 2008; 180(12): 7859 - 7868.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
O. S. Shin, R. R. Isberg, S. Akira, S. Uematsu, A. K. Behera, and L. T. Hu
Distinct Roles for MyD88 and Toll-Like Receptors 2, 5, and 9 in Phagocytosis of Borrelia burgdorferi and Cytokine Induction
Infect. Immun., June 1, 2008; 76(6): 2341 - 2351.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Lampropoulou, K. Hoehlig, T. Roch, P. Neves, E. C. Gomez, C. H. Sweenie, Y. Hao, A. A. Freitas, U. Steinhoff, S. M. Anderton, et al.
TLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity
J. Immunol., April 1, 2008; 180(7): 4763 - 4773.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. F. LaRosa, J. S. Stumhofer, A. E. Gelman, A. H. Rahman, D. K. Taylor, C. A. Hunter, and L. A. Turka
T cell expression of MyD88 is required for resistance to Toxoplasma gondii
PNAS, March 11, 2008; 105(10): 3855 - 3860.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Noor, H. Goldfine, D. E. Tucker, S. Suram, L. L. Lenz, S. Akira, S. Uematsu, M. Girotti, J. V. Bonventre, K. Breuel, et al.
Activation of Cytosolic Phospholipase A2{alpha} in Resident Peritoneal Macrophages by Listeria monocytogenes Involves Listeriolysin O and TLR2
J. Biol. Chem., February 22, 2008; 283(8): 4744 - 4755.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Macedo, G. Pinhal-Enfield, V. Alshits, G. Elson, B. N. Cronstein, and S. J. Leibovich
Wound Healing Is Impaired in MyD88-Deficient Mice: A Role for MyD88 in the Regulation of Wound Healing by Adenosine A2A Receptors
Am. J. Pathol., December 1, 2007; 171(6): 1774 - 1788.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C.-L. Ku, H. von Bernuth, C. Picard, S.-Y. Zhang, H.-H. Chang, K. Yang, M. Chrabieh, A. C. Issekutz, C. K. Cunningham, J. Gallin, et al.
Selective predisposition to bacterial infections in IRAK-4 deficient children: IRAK-4 dependent TLRs are otherwise redundant in protective immunity
J. Exp. Med., October 1, 2007; 204(10): 2407 - 2422.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Hajishengallis, M.-A. K. Shakhatreh, M. Wang, and S. Liang
Complement Receptor 3 Blockade Promotes IL-12-Mediated Clearance of Porphyromonas gingivalis and Negates Its Virulence In Vivo
J. Immunol., August 15, 2007; 179(4): 2359 - 2367.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
K. Brandl, G. Plitas, B. Schnabl, R. P. DeMatteo, and E. G. Pamer
MyD88-mediated signals induce the bactericidal lectin RegIII{gamma} and protect mice against intestinal Listeria monocytogenes infection
J. Exp. Med., August 6, 2007; 204(8): 1891 - 1900.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. Hara, I. Kawamura, T. Nomura, T. Tominaga, K. Tsuchiya, and M. Mitsuyama
Cytolysin-Dependent Escape of the Bacterium from the Phagosome Is Required but Not Sufficient for Induction of the Th1 Immune Response against Listeria monocytogenes Infection: Distinct Role of Listeriolysin O Determined by Cytolysin Gene Replacement
Infect. Immun., August 1, 2007; 75(8): 3791 - 3801.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Plitas, U. I. Chaudhry, T. P. Kingham, J. R. Raab, and R. P. DeMatteo
NK Dendritic Cells Are Innate Immune Responders to Listeria monocytogenes Infection
J. Immunol., April 1, 2007; 178(7): 4411 - 4416.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. S. Way, C. Havenar-Daughton, G. A. Kolumam, N. N. Orgun, and K. Murali-Krishna
IL-12 and Type-I IFN Synergize for IFN-{gamma} Production by CD4 T Cells, Whereas Neither Are Required for IFN-{gamma} Production by CD8 T Cells after Listeria monocytogenes Infection
J. Immunol., April 1, 2007; 178(7): 4498 - 4505.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. Sawaki, H. Tsutsui, N. Hayashi, K. Yasuda, S. Akira, T. Tanizawa, and K. Nakanishi
Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways
Int. Immunol., March 1, 2007; 19(3): 311 - 320.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. D. Bolz, R. S. Sundsbak, Y. Ma, S. Akira, J. H. Weis, T. G. Schwan, and J. J. Weis
Dual Role of MyD88 in Rapid Clearance of Relapsing Fever Borrelia spp.
Infect. Immun., December 1, 2006; 74(12): 6750 - 6760.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Negishi, Y. Fujita, H. Yanai, S. Sakaguchi, X. Ouyang, M. Shinohara, H. Takayanagi, Y. Ohba, T. Taniguchi, and K. Honda
Evidence for licensing of IFN-{gamma}-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program
PNAS, October 10, 2006; 103(41): 15136 - 15141.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. A. Archer and C. R. Roy
MyD88-Dependent Responses Involving Toll-Like Receptor 2 Are Important for Protection and Clearance of Legionella pneumophila in a Mouse Model of Legionnaires' Disease.
Infect. Immun., June 1, 2006; 74(6): 3325 - 3333.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. Marodi
Neonatal Innate Immunity to Infectious Agents
Infect. Immun., April 1, 2006; 74(4): 1999 - 2006.
[Full Text] [PDF]


Home page
Infect. Immun.Home page
A. M. van der Sar, O. W. Stockhammer, C. van der Laan, H. P. Spaink, W. Bitter, and A. H. Meijer
MyD88 Innate Immune Function in a Zebrafish Embryo Infection Model
Infect. Immun., April 1, 2006; 74(4): 2436 - 2441.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Ozoren, J. Masumoto, L. Franchi, T.-D. Kanneganti, M. Body-Malapel, I. Erturk, R. Jagirdar, L. Zhu, N. Inohara, J. Bertin, et al.
Distinct Roles of TLR2 and the Adaptor ASC in IL-1beta/IL-18 Secretion in Response to Listeria monocytogenes
J. Immunol., April 1, 2006; 176(7): 4337 - 4342.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. K. Behera, E. Hildebrand, R. T. Bronson, G. Perides, S. Uematsu, S. Akira, and L. T. Hu
MyD88 Deficiency Results in Tissue-Specific Changes in Cytokine Induction and Inflammation in Interleukin-18-Independent Mice Infected with Borrelia burgdorferi
Infect. Immun., March 1, 2006; 74(3): 1462 - 1470.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
Y.-T.A. Teng
Protective and Destructive Immunity in the Periodontium: Part 1--Innate and Humoral Immunity and the Periodontium
Journal of Dental Research, March 1, 2006; 85(3): 198 - 208.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
L. Romics Jr, A. Dolganiuc, A. Velayudham, K. Kodys, P. Mandrekar, D. Golenbock, E. Kurt-Jones, and G. Szabo
Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes
J. Leukoc. Biol., December 1, 2005; 78(6): 1255 - 1264.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. B. Su, P. B. Silver, R. S. Grajewski, R. K. Agarwal, J. Tang, C.-C. Chan, and R. R. Caspi
Essential Role of the MyD88 Pathway, but Nonessential Roles of TLRs 2, 4, and 9, in the Adjuvant Effect Promoting Th1-Mediated Autoimmunity
J. Immunol., November 15, 2005; 175(10): 6303 - 6310.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Fuse, G. Chan, Y. Liu, P. Gudgeon, M. Husain, M. Chen, W.-C. Yeh, S. Akira, and P. P. Liu
Myeloid Differentiation Factor-88 Plays a Crucial Role in the Pathogenesis of Coxsackievirus B3-Induced Myocarditis and Influences Type I Interferon Production
Circulation, October 11, 2005; 112(15): 2276 - 2285.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
Y. Sasaki, T. Yoshimoto, H. Maruyama, T. Tegoshi, N. Ohta, N. Arizono, and K. Nakanishi
IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell-dependent type 2 innate immunity
J. Exp. Med., September 6, 2005; 202(5): 607 - 616.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Naiki, K. S. Michelsen, N. W. J. Schroder, R. Alsabeh, A. Slepenkin, W. Zhang, S. Chen, B. Wei, Y. Bulut, M. H. Wong, et al.
MyD88 Is Pivotal for the Early Inflammatory Response and Subsequent Bacterial Clearance and Survival in a Mouse Model of Chlamydia pneumoniae Pneumonia
J. Biol. Chem., August 12, 2005; 280(32): 29242 - 29249.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. E. Berg, E. Crossley, S. Murray, and J. Forman
Relative Contributions of NK and CD8 T Cells to IFN-{gamma} Mediated Innate Immune Protection against Listeria monocytogenes
J. Immunol., August 1, 2005; 175(3): 1751 - 1757.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. I Lancaster, Q. Khan, P. Drysdale, F. Wallace, A. E Jeukendrup, M. T Drayson, and M. Gleeson
The physiological regulation of toll-like receptor expression and function in humans
J. Physiol., March 15, 2005; 563(3): 945 - 955.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. O'Connell, S. A. Vaidya, A. K. Perry, S. K. Saha, P. W. Dempsey, and G. Cheng
Immune Activation of Type I IFNs by Listeria monocytogenes Occurs Independently of TLR4, TLR2, and Receptor Interacting Protein 2 but Involves TANK-Binding Kinase 1
J. Immunol., February 1, 2005; 174(3): 1602 - 1607.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Schmieg, G. Yang, R. W. Franck, N. Van Rooijen, and M. Tsuji
Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion
PNAS, January 25, 2005; 102(4): 1127 - 1132.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Liu, X. Guan, T. Tamura, K. Ozato, and X. Ma
Synergistic Activation of Interleukin-12 p35 Gene Transcription by Interferon Regulatory Factor-1 and Interferon Consensus Sequence-binding Protein
J. Biol. Chem., December 31, 2004; 279(53): 55609 - 55617.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
H. Hata, T. Yoshimoto, N. Hayashi, T. Hada, and K. Nakanishi
IL-18 together with anti-CD3 antibody induces human Th1 cells to produce Th1- and Th2-cytokines and IL-8
Int. Immunol., December 1, 2004; 16(12): 1733 - 1739.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
R. Janssen, A. van Wengen, M. A. Hoeve, M. ten Dam, M. van der Burg, J. van Dongen, E. van de Vosse, M. van Tol, R. Bredius, T. H. Ottenhoff, et al.
The Same I{kappa}B{alpha} Mutation in Two Related Individuals Leads to Completely Different Clinical Syndromes
J. Exp. Med., September 7, 2004; 200(5): 559 - 568.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
R. M. O'Connell, S. K. Saha, S. A. Vaidya, K. W. Bruhn, G. A. Miranda, B. Zarnegar, A. K. Perry, B. O. Nguyen, T. F. Lane, T. Taniguchi, et al.
Type I Interferon Production Enhances Susceptibility to Listeria monocytogenes Infection
J. Exp. Med., August 16, 2004; 200(4): 437 - 445.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. D. Bolz, R. S. Sundsbak, Y. Ma, S. Akira, C. J. Kirschning, J. F. Zachary, J. H. Weis, and J. J. Weis
MyD88 Plays a Unique Role in Host Defense but Not Arthritis Development in Lyme Disease
J. Immunol., August 1, 2004; 173(3): 2003 - 2010.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
N. Liu, R. R. Montgomery, S. W. Barthold, and L. K. Bockenstedt
Myeloid Differentiation Antigen 88 Deficiency Impairs Pathogen Clearance but Does Not Alter Inflammation in Borrelia burgdorferi-Infected Mice
Infect. Immun., June 1, 2004; 72(6): 3195 - 3203.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Mancuso, A. Midiri, C. Beninati, C. Biondo, R. Galbo, S. Akira, P. Henneke, D. Golenbock, and G. Teti
Dual Role of TLR2 and Myeloid Differentiation Factor 88 in a Mouse Model of Invasive Group B Streptococcal Disease
J. Immunol., May 15, 2004; 172(10): 6324 - 6329.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. G. Netea, C. van der Graaf, J. W. M. Van der Meer, and B. J. Kullberg
Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system
J. Leukoc. Biol., May 1, 2004; 75(5): 749 - 755.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. Torres, M. Barrier, F. Bihl, V. J. F. Quesniaux, I. Maillet, S. Akira, B. Ryffel, and F. Erard
Toll-Like Receptor 2 Is Required for Optimal Control of Listeria monocytogenes Infection
Infect. Immun., April 1, 2004; 72(4): 2131 - 2139.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. A. Scanga, A. Bafica, C. G. Feng, A. W. Cheever, S. Hieny, and A. Sher
MyD88-Deficient Mice Display a Profound Loss in Resistance to Mycobacterium tuberculosis Associated with Partially Impaired Th1 Cytokine and Nitric Oxide Synthase 2 Expression
Infect. Immun., April 1, 2004; 72(4): 2400 - 2404.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. J. Skerrett, H. D. Liggitt, A. M. Hajjar, and C. B. Wilson
Cutting Edge: Myeloid Differentiation Factor 88 Is Essential for Pulmonary Host Defense against Pseudomonas aeruginosa but Not Staphylococcus aureus
J. Immunol., March 15, 2004; 172(6): 3377 - 3381.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. Kursar, H.-W. Mittrucker, M. Koch, A. Kohler, M. Herma, and S. H. E. Kaufmann
Protective T cell response against intracellular pathogens in the absence of Toll-like receptor signaling via myeloid differentiation factor 88
Int. Immunol., March 1, 2004; 16(3): 415 - 421.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
N. M. Tsuji, H. Tsutsui, E. Seki, K. Kuida, H. Okamura, K. Nakanishi, and R. A. Flavell
Roles of caspase-1 in Listeria infection in mice
Int. Immunol., February 1, 2004; 16(2): 335 - 343.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. G. Feng, C. A. Scanga, C. M. Collazo-Custodio, A. W. Cheever, S. Hieny, P. Caspar, and A. Sher
Mice Lacking Myeloid Differentiation Factor 88 Display Profound Defects in Host Resistance and Immune Responses to Mycobacterium avium Infection Not Exhibited by Toll-Like Receptor 2 (TLR2)- and TLR4-Deficient Animals
J. Immunol., November 1, 2003; 171(9): 4758 - 4764.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. Shi, C. Nathan, D. Schnappinger, J. Drenkow, M. Fuortes, E. Block, A. Ding, T. R. Gingeras, G. Schoolnik, S. Akira, et al.
MyD88 Primes Macrophages for Full-Scale Activation by Interferon-{gamma} yet Mediates Few Responses to Mycobacterium tuberculosis
J. Exp. Med., October 6, 2003; 198(7): 987 - 997.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Lefrancois, A. Marzo, and K. Williams
Sustained Response Initiation Is Required for T Cell Clonal Expansion But Not for Effector or Memory Development In Vivo
J. Immunol., September 15, 2003; 171(6): 2832 - 2839.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Ropert, M. Closel, A. C. L. Chaves, and R. T. Gazzinelli
Inhibition of a p38/Stress-Activated Protein Kinase-2-Dependent Phosphatase Restores Function of IL-1 Receptor-Associated Kinase-1 and Reverses Toll-Like Receptor 2- and 4-Dependent Tolerance of Macrophages
J. Immunol., August 1, 2003; 171(3): 1456 - 1465.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. S. Way, T. R. Kollmann, A. M. Hajjar, and C. B. Wilson
Cutting Edge: Protective Cell-Mediated Immunity to Listeria monocytogenes in the Absence of Myeloid Differentiation Factor 88
J. Immunol., July 15, 2003; 171(2): 533 - 537.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
H. Nakano, H. Tsutsui, M. Terada, K. Yasuda, K. Matsui, S. Yumikura-Futatsugi, K.-i. Yamanaka, H. Mizutani, T. Yamamura, and K. Nakanishi
Persistent secretion of IL-18 in the skin contributes to IgE response in mice
Int. Immunol., May 1, 2003; 15(5): 611 - 621.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seki, E.
Right arrow Articles by Nakanishi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seki, E.
Right arrow Articles by Nakanishi, K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS